Indaptus Therapeutics's three largest insider shareholders as of September 09, 2026 are Michael James Newman (Cso And Director, 1.37Mn shares), Glen R. Anderson (TenPercentOwner, 1.19Mn shares), Michael James Newman (Cso And Director, 101.07K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Glen R. Anderson | TenPercentOwner | 0 | 1,190,400 | 1,190,400 | 85.2% | 16 Aug, 2023 |
| 2 | Michael James Newman | Cso And Director | 101,074 | 0 | 101,074 | 7.2% | 29 Dec, 2025 |
| 3 | Walt Addison Linscott | Chief Operating Officer | 54,576 | 0 | 54,576 | 3.9% | 29 Dec, 2025 |
| 4 | Nir Sassi | Chief Financial Officer | 26,758 | 0 | 26,758 | 1.9% | 29 Dec, 2025 |
| 5 | Avraham Ben-Tzvi | Director | 25,100 | 0 | 25,100 | 1.8% | 22 Jan, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 20 Jan, 2026 | Avraham Ben-Tzvi | Director | Acquired A | 25,000 | $0.00 | $0 | 25,100 | Direct |
| 23 Dec, 2025 | Avraham Ben-Tzvi | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 22 Dec, 2025 | Walt Addison Linscott | Chief Operating Officer | Acquired A | 54,421 | $2.03 | $110.47K | 54,426 | Direct |
| 22 Dec, 2025 | Nir Sassi | Chief Financial Officer | Acquired A | 26,758 | $2.03 | $54.32K | 26,758 | Direct |
| 22 Dec, 2025 | Nir Sassi | Chief Financial Officer | Acquired A | 26,758 | $2.03 | $54.32K | 26,758 | Direct |
| 22 Dec, 2025 | Michael James Newman | Cso And Director | Acquired A | 52,204 | $2.03 | $105.97K | 101,074 | Direct |
| 22 Dec, 2025 | Walt Addison Linscott | Chief Operating Officer | Acquired A | 54,421 | $2.03 | $110.47K | 54,426 | Direct |
| 22 Dec, 2025 | Michael James Newman | Cso And Director | Acquired A | 52,204 | $2.03 | $105.97K | 101,074 | Direct |
| 22 Dec, 2025 | Nir Sassi | Chief Financial Officer | Acquired A | 26,758 | $2.03 | $54.32K | 26,758 | Direct |
| 22 Dec, 2025 | Walt Addison Linscott | Chief Operating Officer | Acquired A | 54,421 | $2.03 | $110.47K | 54,426 | Direct |
| 22 Dec, 2025 | Michael James Newman | Cso And Director | Acquired A | 52,204 | $2.03 | $105.97K | 101,074 | Direct |
| 10 Jun, 2025 | Robert Martell | Director | Acquired A | 12,500 | $0.00 | $0 | 12,500 | Direct |
| 10 Jun, 2025 | William B Hayes | Director | Acquired A | 12,500 | $0.00 | $0 | 6 | Direct |
| 10 Jun, 2025 | Robert Martell | Director | Acquired A | 12,500 | $0.00 | $0 | 12,500 | Direct |
| 10 Jun, 2025 | Robert Martell | Director | Acquired A | 12,500 | $0.00 | $0 | 12,500 | Direct |
| 10 Jun, 2025 | Mark John Gilbert | Director | Acquired A | 12,500 | $0.00 | $0 | 12,500 | Direct |
| 10 Apr, 2025 | Walt Addison Linscott | Chief Operating Officer | Disposed D | 1,750 | $0.06 | $103 | 0 | Direct |
| 10 Apr, 2025 | Nir Sassi | Chief Financial Officer | Disposed D | 1,250 | $0.07 | $89 | 0 | Direct |
| 10 Apr, 2025 | Nir Sassi | Chief Financial Officer | Disposed D | 1,250 | $0.07 | $89 | 0 | Direct |
| 10 Apr, 2025 | Walt Addison Linscott | Chief Operating Officer | Disposed D | 1,750 | $0.06 | $103 | 0 | Direct |